PDL BioPharma Inc (NASDAQ:PDLI)

2.92
Delayed Data
As of 11:52am ET
 +0.035 / +1.22%
Today’s Change
2.11
Today|||52-Week Range
3.55
+6.39%
Year-to-Date
No recent news for PDL BioPharma Inc.

Today’s Trading

Previous close2.88
Today’s open2.91
Day’s range2.88 - 2.94
Volume295,352
Average volume (3 months)1,487,661
Market cap$469.2M
Data as of 11:52am ET, 04/26/2018

Growth & Valuation

Earnings growth (last year)+82.05%
Earnings growth (this year)--
Earnings growth (next 5 years)+17.00%
Revenue growth (last year)+33.54%
P/E ratio4.1
Price/Sales1.34
Price/Book--

Competitors

 Today’s
change
Today’s
% change
NKNantKwest Inc+0.05+1.25%
ATRAAtara Biotherapeutic...+1.25+3.07%
CYADCelyad SA0.000.00%
BCRXBioCryst Pharmaceuti...+0.16+3.29%
Data as of 12:05pm ET, 04/26/2018

Financials

Next reporting dateMay 10, 2018
EPS forecast (this quarter)$0.11
Annual revenue (last year)$320.1M
Annual profit (last year)$110.7M
Net profit margin34.60%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
John Peter McLaughlin
President
Dominique Monnet
Corporate headquarters
Incline Village, Nevada

Forecasts